Pro Share Advisors LLC Ocular Therapeutix, Inc Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 38,601 shares of OCUL stock, worth $382,921. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,601
Previous 25,049 54.1%
Holding current value
$382,921
Previous $171,000 95.91%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$6.45 - $9.23 $87,410 - $125,084
13,552 Added 54.1%
38,601 $335,000
Q2 2024

Aug 13, 2024
SELL
$4.2 - $8.69 $14,485 - $29,971
-3,449 Reduced 12.1%
25,049 $171,000
Q1 2024

May 08, 2024
BUY
$3.85 - $10.93 $39,246 - $111,420
10,194 Added 55.69%
28,498 $259,000
Q4 2023

Feb 14, 2024
BUY
$2.08 - $4.52 $6,208 - $13,492
2,985 Added 19.49%
18,304 $81,000
Q3 2023

Nov 13, 2023
BUY
$3.14 - $5.04 $480 - $771
153 Added 1.01%
15,319 $48,000
Q2 2023

Aug 10, 2023
BUY
$4.6 - $7.64 $3,486 - $5,791
758 Added 5.26%
15,166 $78,000
Q1 2023

May 11, 2023
SELL
$2.79 - $6.27 $5,234 - $11,762
-1,876 Reduced 11.52%
14,408 $75,000
Q4 2022

Feb 02, 2023
BUY
$2.61 - $4.41 $3,387 - $5,724
1,298 Added 8.66%
16,284 $45,000
Q3 2022

Nov 04, 2022
BUY
$4.09 - $6.5 $1,443 - $2,294
353 Added 2.41%
14,986 $62,000
Q2 2022

Aug 01, 2022
SELL
$3.01 - $5.22 $23,125 - $40,105
-7,683 Reduced 34.43%
14,633 $59,000
Q1 2022

May 10, 2022
SELL
$4.83 - $7.35 $25,193 - $38,337
-5,216 Reduced 18.95%
22,316 $111,000
Q4 2021

Feb 08, 2022
BUY
$6.16 - $12.07 $8,297 - $16,258
1,347 Added 5.14%
27,532 $192,000
Q3 2021

Nov 12, 2021
SELL
$9.7 - $14.34 $71,867 - $106,245
-7,409 Reduced 22.05%
26,185 $262,000
Q2 2021

Aug 13, 2021
BUY
$13.43 - $19.16 $49,811 - $71,064
3,709 Added 12.41%
33,594 $476,000
Q1 2021

May 14, 2021
BUY
$15.82 - $22.11 $58,043 - $81,121
3,669 Added 14.0%
29,885 $490,000
Q4 2020

Feb 09, 2021
BUY
$7.91 - $22.95 $207,368 - $601,657
26,216 New
26,216 $543,000
Q4 2019

Feb 12, 2020
SELL
$2.57 - $4.73 $44,975 - $82,775
-17,500 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$3.04 - $5.32 $3,708 - $6,490
1,220 Added 7.49%
17,500 $53,000
Q2 2019

Aug 13, 2019
SELL
$2.46 - $4.52 $3,958 - $7,272
-1,609 Reduced 8.99%
16,280 $72,000
Q1 2019

May 15, 2019
BUY
$3.51 - $4.77 $1,558 - $2,117
444 Added 2.55%
17,889 $71,000
Q4 2018

Feb 14, 2019
BUY
$3.87 - $7.11 $67,512 - $124,033
17,445 New
17,445 $69,000

Others Institutions Holding OCUL

# of Institutions
172
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $764M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email